Palo Alto, CA, United States of America

Maria Jose Costa

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Immune-Onc Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Jose Costa. Retrieved from https://idiyas.com/inventor/maria-jose-costa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Jose Costa: Innovator in Antibody Development

Introduction

Maria Jose Costa is a prominent inventor based in Palo Alto, California. She has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. Her work is focused on advancing therapeutic options for various diseases.

Latest Patents

Maria Jose Costa holds a patent for "Novel Anti-LILRB4 Antibodies and Derivative Products." This innovative patent represents her commitment to creating effective solutions in the medical field. She has achieved this milestone with a total of 1 patent to her name.

Career Highlights

Currently, Maria is associated with Immune-Onc Therapeutics, Inc., where she continues to push the boundaries of scientific research. Her role at the company allows her to collaborate with other talented professionals in the industry.

Collaborations

Among her notable coworkers are Tao Huang and Kyu Hee Hong. Together, they work towards advancing the company's mission and developing groundbreaking therapies.

Conclusion

Maria Jose Costa exemplifies the spirit of innovation in biotechnology through her work on novel antibodies. Her contributions are paving the way for new therapeutic approaches in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…